Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell line

Anti-Cancer Drugs

Volumn 12, Issue 8, 2001, Pages 699-705

  Martinsson, Petra ^a   Liminga, Gunnar ^a   Nygren, Peter ^a   Larsson, Rolf ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticancer treatment; Apoptosis; Caspases; CHS 828; Etoposide; Human lymphoma

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; ETOPOSIDE; LEUCINE; THYMIDINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL SURVIVAL; DNA, NEOPLASM; ETOPOSIDE; HUMANS; IN SITU NICK-END LABELING; KINETICS; LYMPHOMA; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0034843358     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200109000-00009     Document Type: Article

References (36)

1. Apoptosis induced by anticancer drugs
2. Apoptosis and the dilemma of cancer chemotherapy
3. Cell death by apoptosis following anticancer drug treatment in vitro
4. Apoptosis. Its significance in cancer and cancer therapy
5. Apoptosis and cancer chemotherapy
6. Induction of apoptosis by cancer chemotherapy
7. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
8. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
9. Caspases: The proteases of the apoptotic pathway
10. The role of caspases in apoptosis
11. Caspase 8: Igniting the death machine
12. Caspase-9
13. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
14. Emerging roles of caspase-3 in apoptosis
15. Protease inhibitors block apoptosis at intermediate stages: A compared analysis of DNA fragmentation and apoptotic nuclear morphology
16. Measurement of apoptosis
17. Cif (cytochrome c efflux-inducing factor) activity is regulated by Bcl-2 and caspases and correlates with the activation of Bid
18. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
19. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis
20. Etoposide: Four decades of development of a topoisomerase II inhibitor
21. Cell death induced by topoisomerase-targeted drugs: More questions than answers
22. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis
23. Pivotal role of a DEVD-sensitive step in etoposide-induced and fasmediated apoptotic pathways
24. Multiple pathways for apoptotic nuclear fragmentation
25. cAmp increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells
26. Anticancer drug-induced apoptosis in human monocytic leukemic cell line U937 requires activation of endonuclease(s)
27. Establishment and characterization of a human histiocytic lymphoma cell line (U-937)
28. Development of a high-volume in situ mRNA hybridization assay for the qualification of gene expression utilizing scintillating microplates
29. Noninvasive, real-time method for the examination of thymidine uptake events - Application of the method to V-79 cell syncrony studies
30. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)
31. Use of microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias
32. Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis
33. Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis
34. HSP27 inhibits cytochrome c-dependent activation of procaspase-9
35. Cytotoxic drugs and the CD95 pathway
36. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction